Dear members
As many of you know we’ve been doing all we can since our site upgrade to further the issue in the practical ways we can as a patient organisation. This has included assisting with publications and the development of the unprecedented survey the site offers to members.
Survey
The staff of this site continue to shoulder the clinical burden of systemic failures that persist after two decades. To do what we can to address the failure in clinical appreciation of the syndrome, our survey now gathers unprecedented and crucial data to illustrate what is happening to patients. This will ensure future scientific efforts appreciate the broad, novel and heterogenous symptomatic experience of patients. Standardised data is the only way to effectively communicate many facets of the issue and illustrate key realities that we have so far been unable to illustrate.
Many people are interested to know what we will do when we hit the participation goals and what the status is of the project. The next step will be to assemble the methodologies regarding the design, and prepare methods for statistical analysis of the data. The latter, unfortunately, is a lot of technical work. We intend to have this published in some way, and will either prepare and submit this ourselves or ideally partner with a publishing clinical professional with epidemiological experience. We will begin outreach regarding this soon.
We deeply thank everyone who has taken the survey thus far and especially those encouraging other patients to do so. Anyone with a strong familiarity with the R programming language is encouraged to message @awor about assisting in this important work.
Literature review
We are tomorrow publishing on our site a substantial document entitled Post-Finasteride Syndrome as an Epigenetic Post-Androgen Deprivation Syndrome: A potential pathological link between Drug-Induced Androgen Receptor Overexpression and Polyglutamine Toxicity
This is a review of medical literature conducted by the administrators of this site, and was written to support our contact with specialised biologists we believe may be able to pursue basic science research. This is not aimed at a general readership, although the section summarising all published research into PFS may be of general interest.
This has been an internal document for some time, and we were hoping to take time to implement further professional feedback regarding presentation including the commissioning of more illustrative diagrams throughout. However, due to the present uncertainty we have decided to make this available on the site now. We have spent time making this as user friendly as possible and have implemented tooltips for quick access to every citation, a per page bibliography and in page navigation.
Wikipedia
@sugarhouse has helped to publish an update to the wikipedia page of finasteride highlighting PFS and recent evidence regarding the condition. Wikipedia is a trusted resource and the fact the information on finasteride had not been updated to reflect evidence regarding PFS was an overdue omission. This is good news in a time young men are still not appropriately informed by the product labeling or their clinicians about the existence and full extent of this devastating syndrome, despite the majority conclusion of literature reviews on the subject.
I hope also this reaffirms the importance of pulling together to work towards effective achievements.
Organisation of practical research and the impact of Covid 19
At the end of last year we began efforts to gather the interest of scientists with appropriate expertise working with cutting edge technologies. We have been in discussions with scientists in a couple of leading centres to propose, design and (with appropriate fundraising) conduct research that would use next-generation sequencing technologies to hopefully uncover important information about our condition. This would have investigated urgent priorities including the potential for underlying genomic differences in PFS patients that make us variably susceptible to it.
It will come as no surprise that the current global pandemic has effectively halted these efforts. Personally, I am very saddened that this is the case given how hard everyone has worked and the progress made. One of the scientists we were in contact with is at the forefront of what we view as applicable research, and someone I hope will lend their expertise to the issue in the future. It remains to be seen how research funding, cross-border research, and the world economies will recover from this crisis. It is my hope our efforts can be speedily resumed in due course. We are facing a setback here, as millions across the world are.
During the coming months I will of course be helping to manage the site projects and hopefully continuing to work on writing up the design methodologies behind the survey. However, I will be less active directly in the forum. I would like to again thank the staff for the tremendous job they do daily in keeping this site going. As significant mood-related symptoms are a factor for many patients, please ensure the site staff aren’t the target of frustrations during this period, as we all have more than usual to navigate.
I hope you are all coping ok with the additional challenges this strange time brings. Please continue to be brave.
Kind regards,
Axo